Trontinemab: Clinical Trials

3 trials of Trontinemab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 2, Recruiting 1

Follow Trontinemab: new trials by email Literature Review of Trontinemab trials Research Report on Trontinemab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Trontinemab, Placebo - Alzheimer's Disease
Phase 3RecruitingHoffmann-La Roche16002026-10-022026-11-06
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Trontinemab, Placebo - Alzheimers Disease
Phase 3Active not recruitingHoffmann-La Roche10602025-11-122026-09-25
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Trontinemab, Placebo - Alzheimers Disease
Phase 3Active not recruitingHoffmann-La Roche11012025-09-172026-09-25

Conditions studied

Alzheimer Disease (3)  ·  Cognitive Dysfunction (2)

Sponsors

Hoffmann-La Roche (3)

Countries

Argentina (3)  ·  Brazil (3)  ·  Canada (3)  ·  Japan (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Australia (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Chile (1)